Comparison of Intra-Articular and Intravenous Tranexamic Acid for Loss of Blood in Patients Undergoing Total Hip Replacement
Article Sidebar
Main Article Content
Abstract
Background: Tranexamic acid (TXA) is widely used in orthopedic surgeries to minimize blood loss, traditionally administered intravenously. Recent studies have explored intra-articular (IA) administration as a potentially more effective method due to its localized application and reduced systemic absorption.
Objective: To compare the effectiveness of IA and IV TXA in reducing blood loss in patients undergoing total hip replacement (THR).
Methods: This randomized controlled trial was conducted at Jinnah Hospital, Lahore, from August 30, 2019, to February 29, 2020, with approval from the Ethical Review Board. Seventy patients undergoing THR were enrolled and divided into two groups using a lottery system. Group A (n=35) received 1500 mg of IA TXA diluted in 100 ml of saline after implantation of THR components, while Group B (n=35) received 15 mg/kg of IV TXA five minutes before incision. Both groups were operated on using a lateral approach by the same surgeon. Postoperative blood loss was measured, and data were analyzed using SPSS version 20, with a p-value of <0.05 considered significant.
Results: The mean total blood loss in Group A was significantly lower at 446.23 ± 33.81 ml compared to Group B, which had a mean of 928.23 ± 43.93 ml (p-value = 0.0001). The results highlighted a marked reduction in blood loss with IA administration compared to IV.
Conclusion: IA administration of TXA during THR is more effective than IV administration in reducing total blood loss. This study supports the use of IA TXA as a safer, more efficient method for managing blood loss during hip replacement surgeries.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Osteoarthritis Fact Sheet. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/arthritis/basics/osteoathritis.htm. Accessed March 20, 2017.
Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and Out-of-Pocket Costs of Osteoarthritis in the US: Evidence from National Survey Data. Arthritis Rheum. 2009 Dec;60(12):3546-53.
Jafar O, Rehman A, Shaukat MK. Functional Outcome of Total Hip. J Uni Med Dental Coll. 2015;6(3):61-9.
Gililland JM, Anderson LA, Erickson J, Pelt CE, Peters CL. Mean 5-Year Clinical and Radiographic Outcomes of Cementless Total Hip Arthroplasty in Patients Under the Age of 30. Biomed Res Int. 2013;2013:649506.
Streit MR, Schröder K, Körber M, Merle C, Gotterbarm T, Ewerbeck V, et al. High Survival in Young Patients Using a Second Generation Uncemented Total Hip Replacement. Int Orthop. 2012;36:1129-36.
Ueno M, Sonohata M, Fukumori N, Kawano S, Kitajima M, Mawatari M. Comparison between I/A and Intravenous Administration of Tranexamic Acid in Primary Total Hip Arthroplasty. J Orthop Sci. 2016;21:44-7.
Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM. A Systematic Review and Meta-Analysis of the I/A Administration of Tranexamic Acid in Total Hip and Knee Replacement. Bone Joint J. 2014;96-B(8):1005-15.
Khan M, Ahmed A, Umer F, Ahmad S, Ahmed N, Javed S, et al. Total Knee Arthroplasty; Postoperative Mean Loss of Blood with Tranexamic Acid, Is Tranexamic Acid Effective in Reducing Loss of Blood. A Randomized Controlled Trial in Tertiary Care Hospital, Pakistan. Professional Med J. 2017;24:992-6.
Abdel MP, Chalmers BP, Taunton MJ, Pagnano MW, Trousdale RT, Sierra RJ, et al. Intravenous versus I/A Tranexamic Acid in Total Knee Arthroplasty: Both Effective in a Randomized Clinical Trial of 640 Patients. J Bone Joint Surg Am. 2018;100:1023-9.
Longstaff C. Studies on the Mechanisms of Action of Aprotinin and Tranexamic Acid as Plasmin Inhibitors and Antifibrinolytic Agents. Blood Coagul Fibrinolysis. 1994;5:537-42.
Tan J, Chen H, Liu Q. A Meta-Analysis of the Effectiveness and Safety of Using Tranexamic Acid in Primary Unilateral Total Knee Arthroplasty. J Surg Res. 2013;184:880-7.
Charoencholvanich K, Siriwattanasakul P. Tranexamic Acid Reduces Loss of Blood and Blood Transfusion After TKA: A Prospective Randomized Controlled Trial. Clin Orthop Relat Res. 2011;469:2874-80.
Maniar RN, Kumar G, Singhi T. Most Effective Regimen of Tranexamic Acid in Knee Arthroplasty: A Prospective Randomized Controlled Study in 240 Patients. Clin Orthop Relat Res. 2012;470:2605-12.
Camarasa MA, Olle G, Serra-Prat M, et al. Efficacy of Aminocaproic, Tranexamic Acids in the Control of Bleeding During Total Knee Replacement: A Randomized Clinical Trial. Br J Anaesth. 2006;96:576-82.
Sabatini L, Atzori F, Revello S. Intravenous Use of Tranexamic Acid Reduces Postoperative Loss of Blood in Total Knee Arthroplasty. Arch Orthop Trauma Surg. 2014;134:1609-14.
Wong J, Abrishami A, El Beheiry H. I/A Application of Tranexamic Acid Reduces Postoperative Loss of Blood in Total Knee Arthroplasty: A Randomized, Controlled Trial. J Bone Joint Surg Am. 2010;92:2503-13.
Liu Y, Meng F, Yang G, Kong L, Shen Y. Comparison of Intra-Articular Versus Intravenous Application of Tranexamic Acid in Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials. Arch Med Sci. 2017 Apr 1;13(3):533-540.
Mi B, Liu G, Zhou W, Lv H, Liu Y, Zha K, et al. Intra-Articular versus Intravenous Tranexamic Acid Application in Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials. Arch Orthop Trauma Surg. 2017;137(7):997-1009.
Akizuki S, Yasukawa Y, Takizawan T. A New Method of Hemostasis for Cementless Total Knee Arthroplasty. Bull Hosp Jt Dis. 1997;56:222.
Patel JN, Spanyer JM, Smith LS, Huang J, et al. Comparison of Intravenous Versus I/A Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Study. The Journal of Arthroplasty. 2014;29:1528–31.
Seo JG, Moon YW, Park SH. The Comparative Efficacies of Intra-Articular and IV Tranexamic Acid for Reducing Loss of Blood During Total Knee Arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2013;21:1869.
Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of Tranexamic Acid on Surgical Bleeding: Systematic Review and Cumulative Meta-Analysis. BMJ. 2012;344:e3054.
Breau RH, Kokolo MB, Punjani N, Cagiannos I, Beck A, Niznick N, et al. The Effects of Lysine Analogs During Pelvic Surgery: A Systematic Review and Meta-Analysis. Transfus Med Rev. 2014;28:145-55.
Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, LimW. Use of Antifibrinolytic Therapy to Reduce Transfusion in Patients Undergoing Orthopedic Surgery: A Systematic Review of Randomized Trials. Thromb Res. 2009;123:687-96.
Oremus K, Sostaric S, Trkulja V, Haspl M. Influence of Tranexamic Acid on Postoperative Autologous Blood Retransfusion in Primary Total Hip and Knee Arthroplasty: A Randomized Controlled Trial. Transfusion. 2014;54(1):31–41.
North WT, Mehran N, Davis JJ, Silverton CD, Weir RM, Laker MW. I/A vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial. J Arthroplasty. 2016;31(5):1022–1026.
Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Zalve R. I/A Intra-Articular Compared with Intravenous Tranexamic Acid to Reduce Loss of Blood in Primary Total Knee Replacement: A Double-Blind, Randomized, Controlled, Noninferiority Clinical Trial. J Bone Joint Surg Am. 2014;96(23):1937–1944.
Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM. A Systematic Review and Meta-Analysis of the I/A Administration of Tranexamic Acid in Total Hip and Knee Replacement. Bone Joint J. 2014;96-B(8):1005–1015.
Benoni G, Lethagen S, Fredin H. The Effect of Tranexamic Acid on Local and Plasma Fibrinolysis During Total Knee Arthroplasty. Thromb Res. 1997;85(3):195–206.
Suenson E, Lutzen O, Thorsen S. Initial Plasmin-Degradation of Fibrin as the Basis of a Positive Feed-Back Mechanism in Fibrinolysis. Eur J Biochem. 1984;140(3):513–22.
Wei Z, Liu M. The Effectiveness and Safety of Tranexamic Acid in Total Hip or Knee Arthroplasty: A Meta-Analysis of 2720 Cases. Transfus Med. 2015;25(3):151–62.